Recombinant erythropoietin favoured in chemo-related anaemia

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.527, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant erythropoietin favoured in chemo-related anaemia

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods

By Ossa Diego F.  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 223-237

Adis International

Access to resources Recommend Favorite

Recombinant Erythropoietin for Anaemia of Prematurity—When Should Treatment Start?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 37, Iss. 3, 2007-09 ,pp. : 217-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Erythropoietin in Cancer-related Anaemia: a Double-edged Sword?

By Guan X   Chen L  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 1-8

Field House Publishing

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Renal Anaemia in Children: No Justification for Bodyweight-Adjusted Dosage

By Port R.E.  

Clinical Pharmacokinetics, Vol. 43, Iss. 1, 2004-01 ,pp. : 57-70

Adis International

Access to resources Recommend Favorite